Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02197 CLOVER BIO-B
RT Nominal down0.275 -0.005 (-1.786%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others149,720-19.414%185,790155,68965,8974,991
Land & other Lease Assets12,336-77.953%55,95466,71421,09012,437
Intangible Assets39,85913.889%34,99813,828277294
Interests in Asso. & JCEs0--0000
Other Non-current Assets0--28,03532,93451,8394,148

201,915-33.750%304,777269,165139,10321,870
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories696,978-70.769%2,384,340768,69150,881393
Trade Receivables24,106--0000
Cash & Bank Balances735,864-54.220%1,607,4092,767,371516,184148,694
Other Current Assets442,57111.148%398,1801,540,433481,36015,259
Assets Held for Sale0--0000

1,899,519-56.730%4,389,9295,076,4951,048,425164,346
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables247,829-71.081%856,964588,55933,8207,165
S-T Debt & Leases326,5982.823%317,63021,4804,2591,810
Other Current Liabilities1,702,5762.899%1,654,6111,538,07028,65518,512
Liab asso w/ Assets Held for Sale0--0000

2,277,003-19.518%2,829,2052,148,10966,73427,487
Net Current Assets(377,484)--1,560,7242,928,386981,691136,859
Total Assets Less Current Liabilities(175,569)--1,865,5013,197,5511,120,794158,729
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases7,853-78.624%36,73846,44018,05710,645
Other Non-current Liabilities549,411-77.996%2,496,9001,931,9632,085,478215,906

557,264-78.005%2,533,6381,978,4032,103,535226,551
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital8380.359%83574200
  Reserves(733,671)9.671%(668,972)1,218,406(982,741)(67,822)
  Others0--0000
Shareholders' Funds(732,833)9.683%(668,137)1,219,148(982,741)(67,822)
Non-controlling Interests0--0000
Others0--0000

(732,833)9.683%(668,137)1,219,148(982,741)(67,822)
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments16,381-25.750%22,06265,49132,674745
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 25/11/2024 11:54
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB -95,123,000
%Change--
EPS / (LPS)RMB -0.080
NBV Per Share (¥)RMB -0.642
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.